Protein DJ-1 and its anti-oxidative stress function play an important role in renal cell mediated response to profibrotic agents

Molecular BioSystems

Volumn 12, Issue 6, 2016, Pages 1842-1859

  Eltoweissy, Marwa ^a,b   Dihazi, Gry H ^a   Müller, Gerhard A ^a   Asif, Abdul R ^a   Dihazi, Hassan ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Alexandria University Faculty Of Science   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; PROTEIN BINDING; PROTEIN DEGLYCASE DJ-1; PROTEOME; REACTIVE OXYGEN METABOLITE;

ANIMAL; CELL LINE; CELL SURVIVAL; DISEASE MODEL; FIBROSIS; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; KNOCKOUT MOUSE; METABOLISM; MOUSE; MUTATION; OXIDATIVE STRESS; PATHOLOGY; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEOMICS;

ANIMALS; BIOMARKERS; CELL LINE; CELL SURVIVAL; CYTOKINES; DISEASE MODELS, ANIMAL; FIBROSIS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; MICE; MICE, KNOCKOUT; MUTATION; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN DEGLYCASE DJ-1; PROTEIN INTERACTION MAPPING; PROTEIN INTERACTION MAPS; PROTEOME; PROTEOMICS; REACTIVE OXYGEN SPECIES;

EID: 84971333846     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/c5mb00887e     Document Type: Article

References (102)

1. R. C. Harris E. G. Neilson Toward a unified theory of renal progression Annu. Rev. Med. 2006 57 365 380
2. K. A. Nath Tubulointerstitial changes as a major determinant in the progression of renal damage Am. J. Kidney Dis. 1992 20 1 1 17
3. S. Mackensen-Haen R. Bader K. E. Grund A. Bohle Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate Clin. Nephrol. 1981 15 4 167 171
4. F. Strutz and G. A. Mueller, Mechanisms of renal fibrogenesis, in Immunologic renal diseases, ed., E. G. Neilson, and, W. G. Couser, Lippincott Williams & Wilkins, Philadelphia, 2nd edn, 2001, pp. 73-101
5. T. M. Paravicini R. M. Touyz Redox signaling in hypertension Cardiovasc. Res. 2006 71 2 247 258
6. S. V. Shah R. Baliga M. Rajapurkar V. A. Fonecca Oxidants in chronic kidney disease J. Am. Soc. Nephrol. 2007 18 1 16 28
7. K. K. Griendling D. Sorescu M. Ushio-Fukai NAD(P)H oxidase: role in cardiovascular biology and disease Circ. Res. 2000 86 5 494 501
8. S. Rajagopalan S. Kurz T. Muenzel M. Tarpey B. A. Freeman K. K. Griendling D. G. Harrison Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation, Contribution to alterations of vasomotor tone J. Clin. Invest. 1996 97 8 1916 1923
9. Y. Hattori K. Akimoto S. S. Gross S. Hattori K. Kasai Angiotensin II-induced oxidative stress elicits hypoadiponectinaemia in rats Diabetologia 2005 48 6 1066 1074
10. L. Zhang Y. Ma J. Zhang J. Cheng J. Du A new cellular signaling mechanism for angiotensin II activation of NF-kappaB: an IkappaB-independent, RSK-mediated phosphorylation of p65 Arterioscler., Thromb., Vasc. Biol. 2005 25 6 1148 1153
11. J. L. Barnes Y. Gorin Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases Kidney Int. 2011 79 9 944 956
12. A. Sachse G. Wolf Angiotensin II-induced reactive oxygen species and the kidney J. Am. Soc. Nephrol. 2007 18 9 2439 2446
13. J. Nie F. F. Hou Role of reactive oxygen species in the renal fibrosis Chin. Med. J. 2012 125 14 2598 2602
14. M. C. Gongora Z. Qin K. Laude H. W. Kim L. McCann R. J. Folz S. Dikalov T. Fukai D. G. Harrison Role of extracellular superoxide dismutase in hypertension Hypertension 2006 48 3 473 481
15. R. K. Sindhu A. Ehdaie F. Farmand K. K. Dhaliwal T. Nguyen C. D. Zhan C. K. Roberts N. D. Vaziri Expression of catalase and glutathione peroxidase in renal insufficiency Biochim. Biophys. Acta 2005 1743 1-2 86 92
16. M. Eltoweissy G. A. Mueller A. Bibi P. V. Nguye G. H. Dihazi C. A. Mueller H. Dihazi Proteomics analysis identifies PARK7 as an important player for renal cell resistance and survival under oxidative stress Mol. BioSyst. 2011 7 4 1277 1288
17. V. Bonifati B. A. Oostra P. Heutink Linking DJ-1 to neurodegeneration offers novel insights for understanding the pathogenesis of Parkinson's disease J. Mol. Med. 2004 82 3 163 174
18. V. Bonifati P. Rizzu M. J. van Baren O. Schaap G. J. Breedveld E. Krieger M. C. Dekker F. Squitieri P. Ibanez M. Joosse J. W. van Dongen N. Vanacore J. C. van Swieten A. Brice G. Meco C. M. van Duijn B. A. Oostra P. Heutink Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 2003 299 5604 256 259
19. D. Cosgrove D. T. Meehan J. A. Grunkemeyer J. M. Kornak R. Sayers W. J. Hunter G. C. Samuelson Collagen COL4A3 knockout: a mouse model for autosomal Alport syndrome Genes Dev. 1996 10 23 2981 2992
20. V. Ninichuk O. Gross C. Reichel A. Khandoga R. D. Pawar R. Ciubar S. Segerer E. Belemezova E. Radomska B. Luckow G. Perez de Lema P. M. Murphy J. L. Gao A. Henger M. Kretzler R. Horuk M. Weber F. Krombach D. Schlöndorff H. J. Anders Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease J. Am. Soc. Nephrol. 2005 16 4 977 985
21. G. A. Mueller J. Frank H. P. Rodemann G. Engler-Blum Human renal fibroblast cell lines (tFKIF and tNKF) are new tools to investigate pathophysiologic mechanisms of renal interstitial fibrosis Exp. Nephrol. 1995 3 2 127 133
22. M. J. Ryan G. Johnson J. Kirk S. M. Fuerstenberg R. A. Zager B. Torok-Storb HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney Kidney Int. 1994 45 1 48 57
23. H. Dihazi G. H. Dihazi O. Jahn S. Meyer J. Nolte A. R. Asif G. A. Mueller W. Engel Multipotent adult germline stem cells and embryonic stem cells functional proteomics revealed an important role of eukaryotic initiation factor 5A (Eif5a) in stem cell differentiation J. Proteome Res. 2011 10 4 1962 1973
24. D. Wessel U. I. Fluegge A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids Anal. Biochem. 1984 138 1 141 143
25. M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 1976 72 248 254
26. H. Towbin T. Staehelin J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, 1979 Biotechnology 1992 24 145 149
27. T. Taira Y. Saito T. Niki S. M. Iguchi-Ariga K. Takahashi H. Ariga DJ-1 has a role in antioxidative stress to prevent cell death EMBO Rep. 2004 5 2 213 218
28. R. M. Canet-Avilés M. A. Wilson D. W. Miller R. Ahmad C. McLendon S. Bandyopadhyay M. J. Baptista D. Ringe G. A. Petsko M. R. Cookson The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization Proc. Natl. Acad. Sci. U. S. A. 2004 101 24 9103 9108
29. R. H. Kim P. D. Smith H. Aleyasin S. Hayley M. P. Mount S. Pownall A. Wakeham A. J. You-Ten S. K. Kalia P. Horne D. Westaway A. M. Lozano H. Anisman D. S. Park T. W. Mak Hypersensitivity of DJ-1-deficientmice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress Proc. Natl. Acad. Sci. U. S. A. 2005 102 14 5215 5220
30. M. Tanaka M. Asada A. Y. Higashi J. Nakamura A. Oguchi M. Tomita S. Yamada N. Asada M. Takase T. Okuda H. Kawachi A. N. Economides E. Robertson S. Takahashi T. Sakurai R. Goldschmeding E. Muso A. Fukatsu T. Kita M. Yanagita Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome J. Clin. Invest. 2010 120 3 768 777
31. T. Kinumi J. Kimata T. Taira H. Ariga E. Niki Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells Biochem. Biophys. Res. Commun. 2004 317 3 722 728
32. M. A. Wilson The role of cysteine oxidation in DJ-1 function and dysfunction Antioxid. Redox Signaling 2011 15 1 111 122
33. A. C. Witt M. Lakshminarasimhan B. C. Remington S. Hasim E. Pozharski M. A. Wilson Cysteine p Ka depression by a protonated glutamic acid in human DJ-1 Biochemistry 2008 47 28 7430 7440
34. J. Lu A. Holmgren The thioredoxin antioxidant system Free Radical Biol. Med. 2014 66 75 87
35. V. Gerke S. Moss Annexins: form structure to function Physiol. Rev. 2002 82 2 331 371
36. P. A. Madureira R. Hill V. A. Miller C. Giacomantonio P. W. Lee D. M. Waisman Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis Oncotarget 2011 12 1075 1093
37. M. G. Santoro Heat shock factors and the control of the stress response Biochem. Pharmacol. 2000 59 1 55 63
38. G. J. Doherty H. T. McMahon Mediation, modulation, and consequences of membrane-cytoskeleton interactions Annu. Rev. Biophys. 2008 37 65 95
39. J. L. Mazzola M. A. Sirover Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neuro-degenerative disorders? Neurotoxicology 2002 23 4-5 603 609
40. +-induced apoptosis NeuroReport 2001 12 9 2049 2052
41. S. Feo D. Arcuri E. Piddini R. Passantino A. Giallongo ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1) FEBS Lett. 2000 473 1 47 52
42. V. Gupta R. N. Bamezai Human pyruvate kinase M2: A multifunctional protein Protein Sci. 2010 19 11 2031 2044
43. M. Ruiz-Ortega M. Ruperez O. Lorenzo V. Esteban J. Blanco S. Mezzano J. Egido Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney Kidney Int., Suppl. 2002 82 S12 S22
44. S. Klahr J. J. Morrissey The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease Kidney Int., Suppl. 2000 75 S7 S14
45. M. Pawlikowski A. Gruszka S. Mucha G. Mełén-Mucha Angiotensins II and IV stimulate the rat adrenocortical cell proliferation acting via different receptors Endocr. Regul. 2001 35 3 139 142
46. L. Bu S. Qu X. Gao J. J. Zou W. Tang L. L. Sun Z. M. Liu Enhanced angiotensin-converting enzyme 2 attenuates angiotensin II-induced collagen production via AT1 receptor-phosphoinositide 3-kinase-Akt pathway Endocrine 2011 39 2 139 147
47. D. H. Munzenmaier A. S. Greene Opposing actions of angiotensin II on microvascular growth and arterial blood pressure Hypertension 1996 27 3 Pt 2 760 765
48. W. Li Y. Ye B. Fu J. Wang L. Yu T. Ichiki T. Inagami I. Ichikawa X. Chen Genetic deletion of AT2 receptor antagonizes angiotensin II-induced apoptosis in fibroblasts of the mouse embryo Biochem. Biophys. Res. Commun. 1998 250 1 72 76
49. E. Cigola J. Kajstura B. Li L. G. Meggs P. Anversa Angiotensin II activates programmed myocyte cell death in vitro Exp. Cell Res. 1997 231 2 363 371
50. M. Bhaskaran K. Reddy N. Radhakrishanan N. Franki G. Ding P. C. Singhal Angiotensin II induces apoptosis in renal proximal tubular cells Am. J. Physiol. Renal Physiol. 2003 284 5 F955 F965
51. J. C. Bonner Regulation of PDGF and its receptors in fibrotic diseases Cytokine Growth Factor Rev. 2004 15 4 255 273
52. P. Boor A. Konieczny L. Villa U. Kunter C. R. van Roeyen W. J. LaRochelle G. Smithson S. Arrol T. Ostendorf J. Floege PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis Nephrol., Dial., Transplant. 2007 22 5 1323 1331
53. F. Eitner E. Bücher C. van Roeyen U. Kunter S. Rong C. Seikrit L. Villa P. Boor L. Fredriksson G. Bäckström U. Eriksson A. Ostman J. Floege T. Ostendorf PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis J. Am. Soc. Nephrol. 2008 19 2 281 289
54. A. W. Piastowska-Ciesielska K. Dominska M. Nowakowska M. Gajewska A. Gajos-Michniewicz T. Ochedalski Angiotensin modulates human mammary epithelial cell motility J. Renin-Angiotensin-Aldosterone Syst. 2014 15 4 419 429
55. Y. Zhao X. Chen L. Cai Y. Yang G. Sui S. Fu Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway J. Cell. Physiol. 2010 225 1 168 173
56. J. Haendeler B. C. Berk Angiotensin II mediated signal transduction, Important role of tyrosine kinases Regul. Pept. 2000 95 1-3 1 7
57. H. Uemura H. Ishiguro N. Nakaigawa Y. Nagashima Y. Miyoshi K. Fujinami A. Sakaguchi Y. Kubota Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor Mol. Cancer Ther. 2003 2 11 1139 1147
58. S. AbdAlla H. Lother A. M. Abdel-tawab U. Quitterer The angiotensin II AT2 receptor is an AT1 receptor antagonist J. Biol. Chem. 2001 276 43 39721 39726
59. B. I. Levy How to explain the differences between renin angiotensin system modulators Am. J. Hypertens. 2005 18 9 Pt 2 134S 141S
60. K. Domińska A. W. Piastowska E. Rebas A. Lachowicz-Ochedalska The influence of peptides from the angiotensin family on tyrosine kinase activity and cell viability in a human hormone-dependent prostate cancer line Endokrynol. Pol. 2009 60 5 363 369
61. L. Chow L. Rezmann K. Imamura L. Wang K. Catt C. Tikellis W. J. Louis A. G. Frauman S. N. Louis Functional angiotensin II type2 receptors inhibit growth factor signaling in LNCaP and PC3prostate cancer cell lines Prostate 2008 68 6 651 660
62. R. S. Green M. E. Lieb A. S. Weintraub S. N. Gacheru C. L. Rosenfield S. Shah H. M. Kagan M. B. Taubman Identification of lysyl oxidase and other platelet-derived growth factor-inducible genes in vascular smooth muscle cells by differential screening Lab. Invest. 1995 73 4 476 482
63. A. Saridaki G. Panayotou Identification of growth factor-regulated proteins using 2D electrophoresis and mass spectrometry Growth Factors 2005 23 3 223 232
64. F. Yang A. C. Chung X. R. Huang H. Y. Lan Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3 Hypertension 2009 54 4 877 884
65. J. L. Finch E. B. Suarez K. Husain L. Ferder M. C. Cardema D. J. Glenn D. G. Gardner H. Liapis E. Slatopolsky Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremic rats Am. J. Physiol. Renal Physiol. 2012 302 1 F141 F149
66. B. Schieffer M. Luchtefeld S. Braun A. Hilfiker D. Hilfiker-Kleiner H. Drexler Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction Circ. Res. 2000 87 12 1195 1201
67. Z. Xie M. Singh K. Singh ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts J. Cell. Physiol. 2004 198 3 399 407
68. H. Suzuki G. D. Frank H. Utsunomiya S. Higuchi S. Eguchi Current understanding of the mechanism and role of ROS in angiotensin II signal transduction Curr. Pharm. Biotechnol. 2006 7 2 81 86
69. E. N. Haugen A. J. Croatt K. A. Nath Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro Kidney Int. 2000 58 1 144 152
70. G. Wolf E. G. Neilson Angiotensin II as a renal growth factor J. Am. Soc. Nephrol. 1993 3 9 1531 1540
71. Y. Hod Differential control of apoptosis by DJ-1 in prostate benign and cancer cells J. Cell. Biochem. 2004 92 6 1221 1233
72. H. Y. Zhang H. Q. Wang H. M. Liu Y. Guan Z. X. Du Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells Endocr.-Relat. Cancer 2008 15 2 535 544
73. J. Waak S. S. Weber A. Waldenmaier K. Görner M. Alunni-Fabbroni H. Schell D. Vogt-Weisenhorn T. T. Pham V. Reumers V. Baekelandt W. Wurst P. J. Kahle Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1 FASEB J. 2009 23 8 2478 2489
74. A. C. Souza T. Tsuji I. N. Baranova A. V. Bocharov K. J. Wilkins J. M. Street A. Alvarez-Prats X. Hu T. Eggerman P. S. Yuen R. A. Star TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression Physiol. Rep. 2015 3 9 e12558
75. E. Andres-Mateos C. Perier L. Zhang B. Blanchard-Fillion T. M. Greco B. Thomas H. S. Ko M. Sasaki H. Ischiropoulos S. Przedborski T. M. Dawson V. L. Dawson DJ-1 gene deletion reveals that DJ-1 is an a typical peroxiredoxin-like peroxidase Proc. Natl. Acad. Sci. U. S. A. 2007 104 37 14807 14812
76. T. Yokota K. Sugawara K. Ito R. Takahashi H. Ariga H. Mizusawa Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition Biochem. Biophys. Res. Commun. 2003 312 4 1342 1348
77. A. G. Madian J. Hindupur J. D. Hulleman N. Diaz-Maldonado V. R. Mishra E. Guigard C. M. Kay J. C. Rochet F. E. Regnier Effect of single amino acid substitution on oxidative modifications of the Parkinson's disease-related protein, DJ-1 Mol. Cell. Proteomics 2012 11 2 1 15
78. J. Blackinton M. Lakshminarasimhan K. J. Thomas R. Ahmad E. Greggio A. S. Raza M. R. Cookson M. A. Wilson Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1 J. Biol. Chem. 2009 284 10 6476 6485
79. J. Waak S. S. Weber K. Görner C. Schall H. Ichijo T. Stehle P. J. Kahle Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1 J. Biol. Chem. 2009 284 21 14245 14257
80. J. D. Hulleman H. Mirzaei E. Guigard K. L. Taylor S. S. Ray C. M. Kay F. E. Regnier J. C. Rochet Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease Biochemistry 2007 46 19 5776 5789
81. X. Tao L. Tong Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease J. Biol. Chem. 2003 278 33 31372 31379
82. M. A. Wilson J. L. Collins Y. Hod D. Ringe G. A. Petsko The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease Proc. Natl. Acad. Sci. U. S. A. 2003 100 16 9256 9261
83. J. A. Olzmann K. Brown K. D. Wilkinson H. D. Rees Q. Huai H. Ke A. I. Levey L. Li L. S. Chin Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function J. Biol. Chem. 2004 279 9 8506 8515
84. D. J. Moore L. Zhang T. M. Dawson V. L. Dawson A missense mutation (L166P) in DJ-1, linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization J. Neurochem. 2003 87 6 1558 1567
85. M. Lakshminarasimhan M. T. Maldonado W. Zhou A. L. Fink M. A. Wilson Structural impact of three Parkinsonism-associated missense mutations on human DJ-1 Biochemistry 2008 47 5 1381 1392
86. M. S. Bitar C. Liu A. Ziaei Y. Chen T. Schmedt U. V. Jurkunas Decline in DJ-1 and decreased nuclear translocation of Nrf2 in Fuchs endothelial corneal dystrophy Invest. Ophthalmol. Visual Sci. 2012 53 9 5806 5813
87. U. V. Jurkunas M. S. Bitar T. Funaki B. Azizi Evidence of oxidative stress in the pathogenesis of Fuchs endothelial corneal dystrophy Am. J. Pathol. 2010 177 2278 2289
88. C. Liu Y. Chen I. E. Kochevar U. V. Jurkunas Decreased DJ-1 leads to impaired Nrf2-regulated antioxidant defense and increased UV-A-induced apoptosis in corneal endothelial cells Invest. Ophthalmol. Visual Sci. 2014 55 9 5551 5560
89. S. Cuevas Y. Yang P. Konkalmatt L. D. Asico J. Feranil J. Jones V. A. Villar I. Armando P. A. Jose Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1 Hypertension 2015 65 6 1251 1257
90. Y. F. Yan H. P. Chen X. S. Huang L. Y. Qiu Z. P. Liao Q. R. Huang DJ-1 Mediates the Delayed Cardioprotection of Hypoxic Preconditioning Through Activation of Nrf2 and Subsequent Upregulation of Antioxidative Enzymes J. Cardiovasc. Pharmacol. 2015 66 2 148 158
91. Q. Sun Z. Y. Shen Q. T. Meng H. Z. Liu W. N. Duan Z. Y. Xia The role of DJ-1/Nrf2 pathway in the pathogenesis of diabetic nephropathy in rats Renal Failure 2016 38 2 294 304
92. S. Shendelman A. Jonason C. Martinat T. Leete A. Abeliovich DJ-1 is a redox dependent molecular chaperone that inhibits alpha-synuclein aggregate formation PLoS Biol. 2004 2 11 e362
93. W. Zhou M. Zhu M. A. Wilson G. A. Petsko A. L. Fink The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein J. Mol. Biol. 2006 356 4 1036 1048
94. W. Zhou C. R. Freed DJ-1up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity J. Biol. Chem. 2005 280 52 43150 43158
95. F. Liu J. L. Nguyen J. D. Hulleman L. Li J. C. Rochet Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease J. Neurochem. 2008 105 6 2435 2453
96. F. Kamp N. Exner A. K. Lutz N. Wender J. Hegermann B. Brunner B. Nuscher T. Bartels A. Giese K. Beyer S. Eimer K. F. Winklhofer C. Haass Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1 EMBO J. 2010 29 20 3571 3589
97. H. M. Li T. Niki T. Taira S. M. Iguchi-Ariga H. Ariga Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress Free Radical Res. 2005 39 10 1091 1099
98. S. Batelli D. Albani R. Rametta L. Polito F. Prato M. Pesaresi A. Negro G. Forloni DJ-1modulates alpha-synuclein aggregation state in a cellular model of oxidative stress: relevance for Parkinson's disease and involvement of HSP70 PLoS One 2008 3 4 e1884
99. Y. Hod S. N. Pentyala T. C. Whyard M. R. El-Maghrabi Identification and characterization of a novel protein that regulates RNA-protein interaction J. Cell. Biochem. 1999 72 3 435 444
100. H. de Nobel L. Lawrie S. Brul F. Klis M. Davis H. Alloush P. Coote Parallel and comparative analysis of the proteome and transcriptome of sorbic acid-stressed Saccharomyces cerevisiae Yeast 2001 18 15 1413 1428
101. F. Oling J. S. Santos N. Govorukhina C. Mazéres-Dubut W. Bergsma-Schutter G. Oostergetel W. Keegstra O. Lambert A. Lewit-Bentley A. Brisson Structure of membrane-bound annexin A5 trimers: a hybrid cryo-EM- X-ray crystallography study J. Mol. Biol. 2000 304 4 561 573
102. S. Arur U. E. Uche K. Rezaul M. Fong V. Scranton A. E. Cowan W. Mohler D. K. Han Annexin I is an endogenous ligand that mediates apoptotic cell engulfment Dev. Cell 2003 4 4 587 598